Q1 FY27 loss as zero revenue continues; PAT slips to Rs. 1 lakh loss

Revenue DeclinePat NegativeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹15.71

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-4.6% vs market

Commodity Chemicals peers, median of 53sector+0.3%-4.9% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 4.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5+0.1-4.6+0.3-4.9

Next day

-9.1+0.2-9.3-0.1-9.0

-13.6+0.6-14.2-1.2-12.4

-17.9-0.0-17.9-1.6-16.3

-22.0+0.5-22.5+0.1-22.0

-25.8+0.8-26.6-0.9-24.9

-26.2+0.6-26.7-1.3-24.9

15d

-41.1+1.3-42.3-0.4-40.7

-50.4-1.4-49.1-0.1-50.3

—-0.6—-0.5—

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Omkar Pharmachem reported Q1 FY27 unaudited results with net sales of zero and only Rs. 9 lakh in other operating income, down from Rs. 13.50 lakh YoY. The company posted a loss of Rs. 1 lakh versus a profit of Rs. 2.66 lakh last year. Total expenses rose to Rs. 10 lakh. No revenue from core operations.

Likely market impact

Weak results with no core revenue and accumulated losses; negative other equity signals stress. Stock may remain thinly traded.